FDA Shifts To More Cautious Stance On BPA

Law360, New York (January 15, 2010, 3:40 PM EST) -- The U.S. Food and Drug Administration announced Friday that it will work to reduce infants' exposure to controversial chemical bisphenol A and support a more robust regulatory framework for the chemical, responding to concerns about BPA's potential effects on the brain, behavior and prostate gland in fetuses, infants and children.

The FDA said it was taking "reasonable steps" to reduce exposure to BPA in the food supply, including supporting industry actions to stop producing BPA-containing baby bottles and infant feeding cups for the U.S. market, facilitating...
To view the full article, register now.